Geneos Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $26.4K | Sell |
|
|||||
|
2025
Q1 | $60.9K | Buy |
|
|||||
|
2024
Q4 | $12.8K | Hold |
|
|||||
|
2024
Q3 | $10.8K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $965 | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $4K | Sell |
|
|||||
|
2020
Q2 | $39K | Sell |
|
|||||
|
2020
Q1 | $43K | Hold |
|
|||||
|
2019
Q4 | $53K | Buy |
|